190 related articles for article (PubMed ID: 33427507)
1. Simulating drug penetration during hyperthermic intraperitoneal chemotherapy.
Löke DR; Helderman RFCPA; Franken NAP; Oei AL; Tanis PJ; Crezee J; Kok HP
Drug Deliv; 2021 Dec; 28(1):145-161. PubMed ID: 33427507
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of treatment planning software for hyperthermic intraperitoneal chemotherapy in a rat model.
Löke DR; Helderman RFCPA; Rodermond HM; Tanis PJ; Streekstra GJ; Franken NAP; Oei AL; Crezee J; Kok HP
Int J Hyperthermia; 2021; 38(1):38-54. PubMed ID: 33487083
[TBL] [Abstract][Full Text] [Related]
3. The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines.
Helderman RFCPA; Löke DR; Verhoeff J; Rodermond HM; van Bochove GGW; Boon M; van Kesteren S; Garcia Vallejo JJ; Kok HP; Tanis PJ; Franken NAP; Crezee J; Oei AL
Cells; 2020 Jul; 9(8):. PubMed ID: 32722384
[TBL] [Abstract][Full Text] [Related]
4. A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy.
Steuperaert M; Debbaut C; Carlier C; De Wever O; Descamps B; Vanhove C; Ceelen W; Segers P
Drug Deliv; 2019 Dec; 26(1):404-415. PubMed ID: 30929523
[TBL] [Abstract][Full Text] [Related]
5. Application of HIPEC simulations for optimizing treatment delivery strategies.
Löke DR; Kok HP; Helderman RFCPA; Bokan B; Franken NAP; Oei AL; Tuynman JB; Tanis PJ; Crezee J
Int J Hyperthermia; 2023; 40(1):2218627. PubMed ID: 37455017
[TBL] [Abstract][Full Text] [Related]
6. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
[TBL] [Abstract][Full Text] [Related]
7. Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Birgisson H; Enblad M; Artursson S; Ghanipour L; Cashin P; Graf W
Eur J Surg Oncol; 2020 Dec; 46(12):2283-2291. PubMed ID: 32873455
[TBL] [Abstract][Full Text] [Related]
8. Phase II randomized study on tissue distribution and pharmacokinetics of cisplatin according to different levels of intra-abdominal pressure (IAP) during HIPEC (NCT02949791).
Kusamura S; Azmi N; Fumagalli L; Baratti D; Guaglio M; Cavalleri A; Garrone G; Battaglia L; Barretta F; Deraco M
Eur J Surg Oncol; 2021 Jan; 47(1):82-88. PubMed ID: 31262599
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and respiratory implications of high intra-abdominal pressure during HIPEC.
Reis ACV; Kusamura S; Azmi N; Fumagalli L; Piccioni F; Valenza F; Baratti D; Guaglio M; Cavalleri A; Garrone G; Barretta F; Deraco M
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1896-1901. PubMed ID: 32147425
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
[TBL] [Abstract][Full Text] [Related]
11. Mathematical modeling of intraperitoneal drug delivery: simulation of drug distribution in a single tumor nodule.
Steuperaert M; Falvo D'Urso Labate G; Debbaut C; De Wever O; Vanhove C; Ceelen W; Segers P
Drug Deliv; 2017 Nov; 24(1):491-501. PubMed ID: 28181817
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal hyperthermic chemotherapy after cytoreduction in patients with peritoneal metastases from endometrial cancer. The next frontier?
Navarro-Barrios Á; Gil-Martínez J; Ramos-Bernardo I; Barrios P; Muñoz-Casares C; Torres-Melero J; Pereira F; Manzanedo I; Arjona Á; Martínez-Regueira F; Cascales-Campos PA
Surg Oncol; 2020 Jun; 33():19-23. PubMed ID: 32561085
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC).
Zeamari S; Floot B; van der Vange N; Stewart FA
Anticancer Res; 2003; 23(2B):1643-8. PubMed ID: 12820435
[TBL] [Abstract][Full Text] [Related]
14. Effect of intraperitoneal chemotherapy concentration on morbidity and survival.
Elekonawo FMK; van Eden WJ; van der Plas WY; Ewalds RSG; de Jong LAW; Bremers AJA; Hemmer PHJ; Kok NFM; Kruijff S; Aalbers AGJ; de Reuver PR
BJS Open; 2020 Apr; 4(2):293-300. PubMed ID: 31950702
[TBL] [Abstract][Full Text] [Related]
15. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
16. Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastases.
Baratti D; Sammartino P; Kusamura S; Deraco M; ; Ansaloni L; Asero S; Baiocchi G; Bagnoli P; Cavaliere D; Framarini M; Cirocchi R; Coccolini F; Decian F; Delrio P; Sassaroli C; De Simone M; Robella M; Vaira M; Di Giorgio A; Fagotti A; Lorusso D; Federici O; Fiorentini G; Fambrini M; Scaringi S; Garofalo A; Valle M; Gelmini R; Cabry F; Cautero N; Sorrentino L; Graziosi L; Guaglio M; Montenovo M; Bartolini V; Lippolis PV; Macrì A; Pasqual EM; Roviello F; Marrelli D; Orsenigo E; Sommariva A
Eur J Surg Oncol; 2020 May; 46(5):737-739. PubMed ID: 32107093
[No Abstract] [Full Text] [Related]
17. Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: A nationwide comparative study.
Bakkers C; van Erning FN; Rovers KP; Nienhuijs SW; Burger JW; Lemmens VE; Aalbers AG; Kok NF; Boerma D; Brandt AR; Hemmer PH; van Grevenstein WM; de Reuver PR; Tanis PJ; Tuynman JB; de Hingh IH
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1902-1907. PubMed ID: 32340819
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study.
Shimizu T; Sonoda H; Murata S; Takebayashi K; Ohta H; Miyake T; Mekata E; Shiomi H; Naka S; Tani T
Eur J Surg Oncol; 2014 May; 40(5):521-528. PubMed ID: 24388411
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a new valid animal model for the evaluation of hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric rhabdomyosarcoma.
Wagner BR; Adamus AL; Sönnecken D; Vahdad R; Jank P; Denkert C; Mahnken AH; Seitz G
Pediatr Blood Cancer; 2021 Nov; 68(11):e29202. PubMed ID: 34197033
[TBL] [Abstract][Full Text] [Related]
20. Validation of thermal dynamics during Hyperthermic IntraPEritoneal Chemotherapy simulations using a 3D-printed phantom.
Löke DR; Kok HP; Helderman RFCPA; Franken NAP; Oei AL; Tuynman JB; Zweije R; Sijbrands J; Tanis PJ; Crezee J
Front Oncol; 2023; 13():1102242. PubMed ID: 36865797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
